Home » News
Posted on 12/04/2013 by
ViiV Healthcare, a joint venture between Glaxosmithkline and Pfizer, have announced their collaboration with Medicines Patent Pool (MPP) providing lower cost HIV medicines to those in developing countries. Read More
Posted on 25/02/2013 by
The Leahy-Smith America Invents Act (AIA), the most comprehensive review of American Patent Law since the 1950s, was passed into law in September 2011. Read More
Posted on 17/01/2013 by
A 2:1 decision reaffirming Myriad Genetics’ patent rights was made by the U. S. Read More
Posted on 16/01/2013 by
In March 2012 the Indian Patent Office (IPO) granted its first compulsory license to Natco Pharma, an Indian generic manufacturer, revoking the exclusive rights held by Bayer to market Nexavar (sorafenib tosylate). Read More
Posted on 15/01/2013 by
Significant tax reductions are in store for UK-based companies profiting from patented or similarly-protected innovations from 1 April 2013. Read More
Posted on 13/09/2012 by
The Patents Bill had its second reading in Parliament on 12 September 2012, over four years after being first introduced to replace New Zealand’s dated Patents Act 1953. Read More
Posted on 12/09/2012 by
Labour MP Clare Curran has proposed a last minute change to the limitation of the extent to which software inventions may be excluded from patentability. Read More
Posted on 29/08/2012 by
Almost two and a half years after the Commerce Select Committee presented its report on the Patents Bill, progress is again being made towards the replacement of New Zealand’s dated Patents Act 1953. Read More
Posted on 11/07/2012 by
On July 5 2012, the United States Patent and Trademark Office (USPTO) issued guidelines to its patent examiners regarding the patentability of claims relating to ‘laws of nature’ in light of the Supreme Court decision in Mayo Collaborative... Read More
Posted on 06/06/2012 by
Executive summary The Australian Patents Act 1990 has recently been amended. The amendments have the effect of increasing the threshold for inventive step, the standard of disclosure required, and the usefulness of the invention claimed. Read More